Refine your search
Availability
-
Authors
-
Topics
- Biphasic Insulins
- Body Weight
- China
- Cost-Benefit Analysis
- Diabetes Complications
- Diabetes Mellitus, Type 2
- Health Care Costs
- Humans
- Hypoglycemic Agents
- Insulin
- Insulin Aspart
- Insulin, Isophane
- Middle Aged
- Patient Preference
- Quality-Adjusted Life Years
- Republic of Korea
- Taiwan
- Weight Loss
- analogs & derivatives
- drug therapy
- Show more
- Show less
-
Languages